An Overview of the Role of Niemann-Pick C1 (Npc1) in Viral Infections and Inhibition of Viral Infections Through Npc1 Inhibitor Publisher Pubmed



Ahmad I¹ ; Fatemi SN² ; Ghaheri M³ ; Rezvani A⁴ ; Khezri DA⁵ ; Natami M⁶ ; Yasamineh S⁷ ; Gholizadeh O⁷ ; Bahmanyar Z⁸ Show Affiliations
Source: Cell Communication and Signaling Published:2023

Abstract

Viruses communicate with their hosts through interactions with proteins, lipids, and carbohydrate moieties on the plasma membrane (PM), often resulting in viral absorption via receptor-mediated endocytosis. Many viruses cannot multiply unless the host’s cholesterol level remains steady. The large endo/lysosomal membrane protein (MP) Niemann-Pick C1 (NPC1), which is involved in cellular cholesterol transport, is a crucial intracellular receptor for viral infection. NPC1 is a ubiquitous housekeeping protein essential for the controlled cholesterol efflux from lysosomes. Its human absence results in Niemann-Pick type C disease, a deadly lysosomal storage disorder. NPC1 is a crucial viral receptor and an essential host component for filovirus entrance, infection, and pathogenesis. For filovirus entrance, NPC1’s cellular function is unnecessary. Furthermore, blocking NPC1 limits the entry and replication of the African swine fever virus by disrupting cholesterol homeostasis. Cell entrance of quasi-enveloped variants of hepatitis A virus and hepatitis E virus has also been linked to NPC1. By controlling cholesterol levels, NPC1 is also necessary for the effective release of reovirus cores into the cytoplasm. Drugs that limit NPC1’s activity are effective against several viruses, including SARS-CoV and Type I Feline Coronavirus (F-CoV). These findings reveal NPC1 as a potential therapeutic target for treating viral illnesses and demonstrate its significance for several viral infections. This article provides a synopsis of NPC1’s function in viral infections and a review of NPC1 inhibitors that may be used to counteract viral infections. [MediaObject not available: see fulltext.] Graphical Abstract: [Figure not available: see fulltext.]. © 2023, The Author(s).